Adjuvant capesitabine in combination with docetaxel (T), epirubicin (E), and cyclophosphamide (C) in the treatment of early breast cancer (BC): 10-year survival results from the randomized FinXX trial.

Heikki Joensuu, Henrik Lindman, Riikka Huovinen et al.|Journal of Clinical Oncology|2016

Cited by 10